May 12, 2022 5:00pm EDT NeuBase Therapeutics Reports Business Update and Financial Results for the Second Quarter of Fiscal Year 2022
May 02, 2022 4:30pm EDT NeuBase Therapeutics Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2022 Annual Meeting
Mar 13, 2022 7:00pm EDT NeuBase Therapeutics Presents New Preclinical Data at MDA 2022 for Its Myotonic Dystrophy Type 1 Program Demonstrating Splice Rescue, Nuclear Aggregate Resolution, and Myotonia Reversal
Feb 28, 2022 8:00am EST NeuBase Therapeutics to Present New Preclinical Data for Myotonic Dystrophy Type 1 Program at the 2022 MDA Clinical & Scientific Conference
Feb 10, 2022 7:00pm EST NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2022
Dec 23, 2021 4:01pm EST NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2021